# Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

> **NCT06273020** · PHASE4 · UNKNOWN · sponsor: **Hospital Universitario Dr. Jose E. Gonzalez** · enrollment: 60 (estimated)

## Conditions studied

- Ischemic Stroke, Acute
- Diabetes Mellitus, Type 2
- Blood Brain Barrier

## Interventions

- **DRUG:** Cerebrolysin
- **PROCEDURE:** Brain-MRI with contrast after 10-14 days of cerebrolysin

## Key facts

- **NCT ID:** NCT06273020
- **Lead sponsor:** Hospital Universitario Dr. Jose E. Gonzalez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-17
- **Primary completion:** 2024-11
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06273020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06273020, "Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06273020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*